ScreenerHero

MTNBMATINAS BIOPHARMA HOLDINGS, INC.

AMEX · US · Healthcare · Biotechnology · matinasbiopharma.com
0.1988USD-17.51%Mkt Cap: 2.92M $P/E: —

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology p…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap2.92M $
Enterprise Value2.17M $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-10.35M $
Revenue/Share—
Last Price0.1988 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5768101058
Valuation
P/E (Trailing)—
P/E (Forward)-0.07
PEG—
EV/EBITDA-0.33
EV/Revenue—
P/S—
P/B0.71
EPS (TTM)-1.15
EPS (Forward)-3.00
52W Range
0.18011% of range2.242
52W High2.242 USD
52W Low0.1801 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-214.18%
ROA-143.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.01M $
CapEx (TTM)—
FCF Margin—
FCF Yield-83.83%
Net Debt-755.00K $
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity0.28
Current Ratio0.85
Quick Ratio0.56
Book Value/Sh0.2810 USD
Cash/Share0.0520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateSep 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.69M
Float11.45M
Insiders23.75%
Institutions2.21%
Short Interest
Short Ratio0.1d
Short % Float13.14%
Short % Out.13.11%
Shares Short839.99K
Short (prev mo.)6.11K
Technical
SMA 500.4365 (-54.5%)
SMA 2000.6304 (-68.5%)
Beta1.75
S&P 52W Chg19.18%
Avg Vol (30d)9.23M
Avg Vol (10d)1.95M
Technical Indicators
RSI (14)30.3
MACD-0.0623
MACD Signal-0.0686
MACD Hist.+0.0063
BB Upper0.3360 USD
BB Middle0.2672 USD
BB Lower0.1983 USD
BB Width51.52%
ATR (14)0.0534 USD
Vol Ratio (20d)0.06x